調査レポート | • レポートコード：QYR2104Z5451 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、スティル病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（セルトリズマブペゴル、DNX-514、エタネルセプト、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・スティル病治療の市場動向 ・企業の競争状況、市場シェア ・スティル病治療の種類別市場規模（セルトリズマブペゴル、DNX-514、エタネルセプト、その他） ・スティル病治療の用途別市場規模（クリニック、病院、その他） ・スティル病治療の北米市場規模2016-2027（アメリカ、カナダ） ・スティル病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・スティル病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・スティル病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・スティル病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biocon Limited、Epirus Biopharmaceuticals, Inc.、Genor BioPharma Co., Ltd.、Hetero Drugs Limited、Mabion SA、Mycenax Biotech Inc.、Oncobiologics, Inc.、Oncodesign SA、Panacea Biotec Limited、Pfizer Inc.、Sandoz International GmbH、Swedish Orphan Biovitrum AB、Therapeutic Proteins International, LLC、UCB S.A.） ・結論 |
Market Analysis and Insights: Global Still’s Disease Treatment Market
The global Still’s Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Still’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Still’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Still’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Still’s Disease Treatment market.
Global Still’s Disease Treatment Scope and Market Size
Still’s Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Still’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Certolizumab Pegol
DNX-514
Etanercept
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Biocon Limited
Epirus Biopharmaceuticals, Inc.
Genor BioPharma Co., Ltd.
Hetero Drugs Limited
Mabion SA
Mycenax Biotech Inc.
Oncobiologics, Inc.
Oncodesign SA
Panacea Biotec Limited
Hetero Drugs Limited
Mabion SA
Swedish Orphan Biovitrum AB
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Still’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Certolizumab Pegol
1.2.3 DNX-514
1.2.4 Etanercept
1.2.5 Others
1.3 Market by Application
1.3.1 Global Still’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Still’s Disease Treatment Market Perspective (2016-2027)
2.2 Still’s Disease Treatment Growth Trends by Regions
2.2.1 Still’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Still’s Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Still’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Still’s Disease Treatment Industry Dynamic
2.3.1 Still’s Disease Treatment Market Trends
2.3.2 Still’s Disease Treatment Market Drivers
2.3.3 Still’s Disease Treatment Market Challenges
2.3.4 Still’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Still’s Disease Treatment Players by Revenue
3.1.1 Global Top Still’s Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Still’s Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Still’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Still’s Disease Treatment Revenue
3.4 Global Still’s Disease Treatment Market Concentration Ratio
3.4.1 Global Still’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Still’s Disease Treatment Revenue in 2020
3.5 Still’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Still’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Still’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Still’s Disease Treatment Breakdown Data by Type
4.1 Global Still’s Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Still’s Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Still’s Disease Treatment Breakdown Data by Application
5.1 Global Still’s Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Still’s Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Still’s Disease Treatment Market Size (2016-2027)
6.2 North America Still’s Disease Treatment Market Size by Type
6.2.1 North America Still’s Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Still’s Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Still’s Disease Treatment Market Size by Type (2016-2027)
6.3 North America Still’s Disease Treatment Market Size by Application
6.3.1 North America Still’s Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Still’s Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Still’s Disease Treatment Market Size by Application (2016-2027)
6.4 North America Still’s Disease Treatment Market Size by Country
6.4.1 North America Still’s Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Still’s Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Still’s Disease Treatment Market Size (2016-2027)
7.2 Europe Still’s Disease Treatment Market Size by Type
7.2.1 Europe Still’s Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Still’s Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Still’s Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Still’s Disease Treatment Market Size by Application
7.3.1 Europe Still’s Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Still’s Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Still’s Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Still’s Disease Treatment Market Size by Country
7.4.1 Europe Still’s Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Still’s Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Still’s Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Still’s Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Still’s Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Still’s Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Still’s Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Still’s Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Still’s Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Still’s Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Still’s Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Still’s Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Still’s Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Still’s Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Still’s Disease Treatment Market Size (2016-2027)
9.2 Latin America Still’s Disease Treatment Market Size by Type
9.2.1 Latin America Still’s Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Still’s Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Still’s Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Still’s Disease Treatment Market Size by Application
9.3.1 Latin America Still’s Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Still’s Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Still’s Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Still’s Disease Treatment Market Size by Country
9.4.1 Latin America Still’s Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Still’s Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Still’s Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Still’s Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Still’s Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Still’s Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Still’s Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Still’s Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Still’s Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Still’s Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Still’s Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Still’s Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Still’s Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Still’s Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biocon Limited
11.1.1 Biocon Limited Company Details
11.1.2 Biocon Limited Business Overview
11.1.3 Biocon Limited Still’s Disease Treatment Introduction
11.1.4 Biocon Limited Revenue in Still’s Disease Treatment Business (2016-2021)
11.1.5 Biocon Limited Recent Development
11.2 Epirus Biopharmaceuticals, Inc.
11.2.1 Epirus Biopharmaceuticals, Inc. Company Details
11.2.2 Epirus Biopharmaceuticals, Inc. Business Overview
11.2.3 Epirus Biopharmaceuticals, Inc. Still’s Disease Treatment Introduction
11.2.4 Epirus Biopharmaceuticals, Inc. Revenue in Still’s Disease Treatment Business (2016-2021)
11.2.5 Epirus Biopharmaceuticals, Inc. Recent Development
11.3 Genor BioPharma Co., Ltd.
11.3.1 Genor BioPharma Co., Ltd. Company Details
11.3.2 Genor BioPharma Co., Ltd. Business Overview
11.3.3 Genor BioPharma Co., Ltd. Still’s Disease Treatment Introduction
11.3.4 Genor BioPharma Co., Ltd. Revenue in Still’s Disease Treatment Business (2016-2021)
11.3.5 Genor BioPharma Co., Ltd. Recent Development
11.4 Hetero Drugs Limited
11.4.1 Hetero Drugs Limited Company Details
11.4.2 Hetero Drugs Limited Business Overview
11.4.3 Hetero Drugs Limited Still’s Disease Treatment Introduction
11.4.4 Hetero Drugs Limited Revenue in Still’s Disease Treatment Business (2016-2021)
11.4.5 Hetero Drugs Limited Recent Development
11.5 Mabion SA
11.5.1 Mabion SA Company Details
11.5.2 Mabion SA Business Overview
11.5.3 Mabion SA Still’s Disease Treatment Introduction
11.5.4 Mabion SA Revenue in Still’s Disease Treatment Business (2016-2021)
11.5.5 Mabion SA Recent Development
11.6 Mycenax Biotech Inc.
11.6.1 Mycenax Biotech Inc. Company Details
11.6.2 Mycenax Biotech Inc. Business Overview
11.6.3 Mycenax Biotech Inc. Still’s Disease Treatment Introduction
11.6.4 Mycenax Biotech Inc. Revenue in Still’s Disease Treatment Business (2016-2021)
11.6.5 Mycenax Biotech Inc. Recent Development
11.7 Oncobiologics, Inc.
11.7.1 Oncobiologics, Inc. Company Details
11.7.2 Oncobiologics, Inc. Business Overview
11.7.3 Oncobiologics, Inc. Still’s Disease Treatment Introduction
11.7.4 Oncobiologics, Inc. Revenue in Still’s Disease Treatment Business (2016-2021)
11.7.5 Oncobiologics, Inc. Recent Development
11.8 Oncodesign SA
11.8.1 Oncodesign SA Company Details
11.8.2 Oncodesign SA Business Overview
11.8.3 Oncodesign SA Still’s Disease Treatment Introduction
11.8.4 Oncodesign SA Revenue in Still’s Disease Treatment Business (2016-2021)
11.8.5 Oncodesign SA Recent Development
11.9 Panacea Biotec Limited
11.9.1 Panacea Biotec Limited Company Details
11.9.2 Panacea Biotec Limited Business Overview
11.9.3 Panacea Biotec Limited Still’s Disease Treatment Introduction
11.9.4 Panacea Biotec Limited Revenue in Still’s Disease Treatment Business (2016-2021)
11.9.5 Panacea Biotec Limited Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Details
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Still’s Disease Treatment Introduction
11.10.4 Pfizer Inc. Revenue in Still’s Disease Treatment Business (2016-2021)
11.10.5 Pfizer Inc. Recent Development
11.11 Sandoz International GmbH
11.11.1 Sandoz International GmbH Company Details
11.11.2 Sandoz International GmbH Business Overview
11.11.3 Sandoz International GmbH Still’s Disease Treatment Introduction
11.11.4 Sandoz International GmbH Revenue in Still’s Disease Treatment Business (2016-2021)
11.11.5 Sandoz International GmbH Recent Development
11.12 Swedish Orphan Biovitrum AB
11.12.1 Swedish Orphan Biovitrum AB Company Details
11.12.2 Swedish Orphan Biovitrum AB Business Overview
11.12.3 Swedish Orphan Biovitrum AB Still’s Disease Treatment Introduction
11.12.4 Swedish Orphan Biovitrum AB Revenue in Still’s Disease Treatment Business (2016-2021)
11.12.5 Swedish Orphan Biovitrum AB Recent Development
11.13 Therapeutic Proteins International, LLC
11.13.1 Therapeutic Proteins International, LLC Company Details
11.13.2 Therapeutic Proteins International, LLC Business Overview
11.13.3 Therapeutic Proteins International, LLC Still’s Disease Treatment Introduction
11.13.4 Therapeutic Proteins International, LLC Revenue in Still’s Disease Treatment Business (2016-2021)
11.13.5 Therapeutic Proteins International, LLC Recent Development
11.14 UCB S.A.
11.14.1 UCB S.A. Company Details
11.14.2 UCB S.A. Business Overview
11.14.3 UCB S.A. Still’s Disease Treatment Introduction
11.14.4 UCB S.A. Revenue in Still’s Disease Treatment Business (2016-2021)
11.14.5 UCB S.A. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Still's Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Certolizumab Pegol
Table 3. Key Players of DNX-514
Table 4. Key Players of Etanercept
Table 5. Key Players of Others
Table 6. Global Still's Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Still's Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Still's Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Still's Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Still's Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Still's Disease Treatment Market Share by Regions (2022-2027)
Table 12. Still's Disease Treatment Market Trends
Table 13. Still's Disease Treatment Market Drivers
Table 14. Still's Disease Treatment Market Challenges
Table 15. Still's Disease Treatment Market Restraints
Table 16. Global Still's Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Still's Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Still's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Still's Disease Treatment as of 2020)
Table 19. Ranking of Global Top Still's Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Still's Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Still's Disease Treatment Product Solution and Service
Table 23. Date of Enter into Still's Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Still's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Still's Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Still's Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Still's Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Still's Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Still's Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Still's Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Still's Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Still's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Still's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Still's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Still's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Still's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Still's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Still's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Still's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Still's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Still's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Still's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Still's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Still's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Still's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Still's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Still's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Still's Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Still's Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Still's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Still's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Still's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Still's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Still's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Still's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Still's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Still's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Still's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Still's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Still's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Still's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Biocon Limited Company Details
Table 64. Biocon Limited Business Overview
Table 65. Biocon Limited Still's Disease Treatment Product
Table 66. Biocon Limited Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. Biocon Limited Recent Development
Table 68. Epirus Biopharmaceuticals, Inc. Company Details
Table 69. Epirus Biopharmaceuticals, Inc. Business Overview
Table 70. Epirus Biopharmaceuticals, Inc. Still's Disease Treatment Product
Table 71. Epirus Biopharmaceuticals, Inc. Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. Epirus Biopharmaceuticals, Inc. Recent Development
Table 73. Genor BioPharma Co., Ltd. Company Details
Table 74. Genor BioPharma Co., Ltd. Business Overview
Table 75. Genor BioPharma Co., Ltd. Still's Disease Treatment Product
Table 76. Genor BioPharma Co., Ltd. Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. Genor BioPharma Co., Ltd. Recent Development
Table 78. Hetero Drugs Limited Company Details
Table 79. Hetero Drugs Limited Business Overview
Table 80. Hetero Drugs Limited Still's Disease Treatment Product
Table 81. Hetero Drugs Limited Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. Hetero Drugs Limited Recent Development
Table 83. Mabion SA Company Details
Table 84. Mabion SA Business Overview
Table 85. Mabion SA Still's Disease Treatment Product
Table 86. Mabion SA Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. Mabion SA Recent Development
Table 88. Mycenax Biotech Inc. Company Details
Table 89. Mycenax Biotech Inc. Business Overview
Table 90. Mycenax Biotech Inc. Still's Disease Treatment Product
Table 91. Mycenax Biotech Inc. Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Mycenax Biotech Inc. Recent Development
Table 93. Oncobiologics, Inc. Company Details
Table 94. Oncobiologics, Inc. Business Overview
Table 95. Oncobiologics, Inc. Still's Disease Treatment Product
Table 96. Oncobiologics, Inc. Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. Oncobiologics, Inc. Recent Development
Table 98. Oncodesign SA Company Details
Table 99. Oncodesign SA Business Overview
Table 100. Oncodesign SA Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 101. Oncodesign SA Recent Development
Table 102. Panacea Biotec Limited Company Details
Table 103. Panacea Biotec Limited Business Overview
Table 104. Panacea Biotec Limited Still's Disease Treatment Product
Table 105. Panacea Biotec Limited Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 106. Panacea Biotec Limited Recent Development
Table 107. Pfizer Inc. Company Details
Table 108. Pfizer Inc. Business Overview
Table 109. Pfizer Inc. Still's Disease Treatment Product
Table 110. Pfizer Inc. Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 111. Pfizer Inc. Recent Development
Table 112. Sandoz International GmbH Company Details
Table 113. Sandoz International GmbH Business Overview
Table 114. Sandoz International GmbH Still's Disease Treatment Product
Table 115. Sandoz International GmbH Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 116. Sandoz International GmbH Recent Development
Table 117. Swedish Orphan Biovitrum AB Company Details
Table 118. Swedish Orphan Biovitrum AB Business Overview
Table 119. Swedish Orphan Biovitrum AB Still's Disease Treatment Product
Table 120. Swedish Orphan Biovitrum AB Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 121. Swedish Orphan Biovitrum AB Recent Development
Table 122. Therapeutic Proteins International, LLC Company Details
Table 123. Therapeutic Proteins International, LLC Business Overview
Table 124. Therapeutic Proteins International, LLC Still's Disease Treatment Product
Table 125. Therapeutic Proteins International, LLC Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 126. Therapeutic Proteins International, LLC Recent Development
Table 127. UCB S.A. Company Details
Table 128. UCB S.A. Business Overview
Table 129. UCB S.A. Still's Disease Treatment Product
Table 130. UCB S.A. Revenue in Still's Disease Treatment Business (2016-2021) & (US$ Million)
Table 131. UCB S.A. Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Still's Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Certolizumab Pegol Features
Figure 3. DNX-514 Features
Figure 4. Etanercept Features
Figure 5. Others Features
Figure 6. Global Still's Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Others Case Studies
Figure 10. Still's Disease Treatment Report Years Considered
Figure 11. Global Still's Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Still's Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Still's Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Still's Disease Treatment Market Share by Regions (2022-2027)
Figure 15. Global Still's Disease Treatment Market Share by Players in 2020
Figure 16. Global Top Still's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Still's Disease Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Still's Disease Treatment Revenue in 2020
Figure 18. Global Still's Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Still's Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Still's Disease Treatment Market Share by Type (2016-2027)
Figure 22. North America Still's Disease Treatment Market Share by Application (2016-2027)
Figure 23. North America Still's Disease Treatment Market Share by Country (2016-2027)
Figure 24. United States Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Still's Disease Treatment Market Share by Type (2016-2027)
Figure 28. Europe Still's Disease Treatment Market Share by Application (2016-2027)
Figure 29. Europe Still's Disease Treatment Market Share by Country (2016-2027)
Figure 30. Germany Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Still's Disease Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Still's Disease Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Still's Disease Treatment Market Share by Region (2016-2027)
Figure 40. China Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Still's Disease Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Still's Disease Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Still's Disease Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Still's Disease Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Still's Disease Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Still's Disease Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Still's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Biocon Limited Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 60. Epirus Biopharmaceuticals, Inc. Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 61. Genor BioPharma Co., Ltd. Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 62. Hetero Drugs Limited Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 63. Mabion SA Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 64. Mycenax Biotech Inc. Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 65. Oncobiologics, Inc. Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 66. Oncodesign SA Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 67. Panacea Biotec Limited Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 68. Pfizer Inc. Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 69. Sandoz International GmbH Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 70. Swedish Orphan Biovitrum AB Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 71. Therapeutic Proteins International, LLC Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 72. UCB S.A. Revenue Growth Rate in Still's Disease Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…- 世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年） Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …
- 世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 世界のレイノー病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Raynauds Disease Treatment Market The global Raynauds Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界のニューカッスル病治療市場規模・現状・予測（2021年-2027年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…